Pancreas
-
A Phase 2 Study of Combination Immunotherapy Plus Standard-of-Care Chemotherapy
Versus Standard-of-Care Chemotherapy for First and Second Line Treatment
of Locally Advanced or Metastatic Pancreatic Cancer (Phase 2 immunotherapy clinical trial for locally advanced or metastatic
pancreatic cancer)
-
(107-18) A Phase 1b/2 Study of BMS-813160 in Combination with Chemotherapy
or Nivolumab in Patients with Advanced Solid Tumors (Phase 1b/2 clinical trial, appropriate for patients with colorectal or
pancreatic cancer.)
-
(113-16) Data Registry for Pancreatic Cancer Early Detection: Prospective
Data Collection and Analysis (Appropriate for patients with pancreatic cancer.)
- (119-17) Noncoding RNA Biomarkers for Noninvasive and Early Detection of
Pancreatic Cancer (Research study, appropriate for patients with pancreatic cancer.)
-
(131-17) A Phase 1/2 Safety Study of Intratumorally Administered INT230-6
in Adult Subjects with Advanced Refractory Cancers (Phase 1 clinical trial, appropriate for patients with solid tumors.)
-
(144-17) Guadecitabine and Durvalumab in Treating Patients With Advanced
Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (Phase 1b clinical trial, appropriate for patients with hepatocellular,
pancreatic, and cholangiocarcinoma / gallbladder cancers.)
- (167-17) Caris ctDNA Validation Project (Research study, appropriate for
patients with all solid tumors.)
-
(211-17) Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate
Hepatic Impairment Patients (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
Certain clinical trials may not be listed on ClinicalTrials.gov. To learn
more about these or other clinical trials, please call 949-764-5543 or
contact us online.